President Trump's threatened 30% tariffs on the EU might prompt some businesses to take another look at the U.K.

Weight loss drugs could be a gamechanger for women with a common hormonal disorder

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of women in the U.S.

Earnings playbook: The reporting season heats up with Alphabet and Tesla on deck

More than 100 S&P 500 names are scheduled to post their latest quarterly figures this week.

"At that 30% level ... it will be a lose-lose situation," one distillery boss told CNBC.

Canadian travel dropped sharply in the first half of 2025, according to numbers by U.S. Travel Association.

Sarepta reported a third death tied to its gene therapies.

American Express said Friday that travel spending in the quarter was weaker than transactions for goods and services.

Global insured losses for the first half of this year have reached $84 billion, according to a recent Gallagher Re report.

Consumers' worst fears about tariff-induced inflation have receded, though they are still wary of price increases to come.

U.S. airlines are struggling from weaker domestic spring and summer demand and lower fares.